Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus

  • OKI Eishin
    Department of Pediatrics, Hirosaki University School of Medicine
  • TSUGAWA Koji
    Department of Pediatrics, Hirosaki University School of Medicine
  • SUZUKI Koichi
    Department of Pediatrics, Hirosaki University School of Medicine
  • TANAKA Hiroshi
    Department of Pediatrics, Hirosaki University School of Medicine

Bibliographic Information

Other Title
  • 少量タクロリムス療法が有効であった再燃を繰り返す全身性エリテマトーデス症例
  • ショウリョウ タクロリムス リョウホウ ガ ユウコウ デ アッタ サイネン オ クリカエス ゼンシンセイ エリテマトーデス ショウレイ

Search this article

Abstract

It has been reported that aggressive immunosuppressive treatment is effective for controlling the disease activity of refractory systemic lupus erythematosus (SLE). However, little information on a regimen including tacrolimus (TL) for the treatment of refractory SLE has been available. We report a successful low dose TL treatment of a 25-year-old male patient with refractory SLE. He developed SLE with proliferative lupus nephritis (WHO class IVb) at the age of 11 years. During the past 4 years, despite aggressive immunosuppressive treatment consisting of methylprednisolone pulse therapy, mizoribine pulse therapy, cyclosporine A and intravenous cyclophosphamide pulse therapy, frequent flares associated with presumptive hypercytokinemia i.e., increased levels in the serum C-reactive protein, ferritin and soluble IL-2 receptor, occurred. Hence, administration of low-dose TL at 3mg per day, was initiated. The blood levels of TL at approximately 12 hours post-dosing were maintained at between 3 and 5ng/mL. Within 3 weeks following TL administration, the serum levels of C3, C4 and CH50 began to increase rapidly, and the prednisolone dose could be successfully tapered. No adverse effects of TL were observed.<br>We suggest that TL may be the treatment of choice for selected patients with refractory SLE.

Journal

Citations (1)*help

See more

References(10)*help

See more

Details 詳細情報について

Report a problem

Back to top